NEW YORK and KISSING, Germany, March 8 /PRNewswire/ -- invendo medical announced today that the company has filed its 510(k) notice submission with the Food and Drug Administration for premarket clearance of the company’s new C20(TM) colonoscopy system including the SC20(TM) single-use colonoscope. This is the first FDA submission for invendo medical in the United States.
The C20(TM) colonoscopy system has already received CE mark in Europe.
About invendo medical - www.invendo-medical.com
Based in New York, U.S.A. and Kissing (near Munich), Germany, invendo medical is a leading developer of disposable endoscopy products in the field of gastroenterology that are hygienically safe and employ “no manual push” remote control advancement technology.
invendo medical
